REQUEST A DEMO
Total
USD $0.00
Search more companies

Chongqing Lummy Pharmaceutical Co.,Ltd (China)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Chongqing Lummy Pharmaceutical Co.,Ltd Profile Updated: October 27, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Chinese Download a sample report

Chongqing Lummy Pharmaceutical Co., Ltd is a high-tech pharmaceutical company located in Chongqing. The company was established in 2011 and has since been recognized as a "National Biotechnology Industry Base Leading Enterprise" and a "National Torch Plan Key High-tech Enterprise". In 2012, it was also recognized as a "National Innovative (Pilot) Enterprise", a "Chinese Pharmaceutical Research and Development Product Line Industrial Enterprise", an "Innovative Enterprise in Chongqing", a "Chongqing Technology Innovation Demonstration Enterprise", and a "Chongqing Intellectual Property Pilot Unit". The company has been rated as an AAA credit enterprise. Its trademark "Lummy" has been recognized as a "Famous Trademark in Chongqing", and its various products have been awarded as "Chongqing High-tech Products", "Chongqing Key New Products", "Chongqing Famous Brand Products", and "Chongqing Well-known Products". The company has strong research and development capabilities, with two research and development platforms, the "Chongqing Lummy Pharmaceutical Technology Center" and the "Lummy-Sichuan University Joint Laboratory". It also has a "Municipal Enterprise Technology Center" in Chongqing and a "Chongqing Drug Quality Control Engineering Technology Research Center" jointly established with the US-listed company American Sajin Pharmaceutical. The company is one of the earliest enterprises in China to obtain GMP and GSP certifications. It has production bases in Chongqing Tea Garden New Area, Chongqing Changshou Chemical Industrial Park, Hunan Changsha Liuyang, Yiyang, and Chengdu High-tech Zone. The company has a rich product portfolio, including all types of injectables such as large and small volume injections, powder injections, and lyophilized powder injections, making it one of the most comprehensive pharmaceutical production companies in China for injectable dosage forms.

Headquarters
15th Floor, 16th Floor, Building B, Chongqing Academy of Science and Technology, No. 2 Yangliu Road, Huangshan Avenue, Yubei District, Chongqing
Chongqing; Chongqing; Postal Code: 401121

Contact Details: Purchase the Chongqing Lummy Pharmaceutical Co.,Ltd report to view the information.

Website: http://www.cqlummy.com

Basic Information
Total Employees:
Purchase the Chongqing Lummy Pharmaceutical Co.,Ltd report to view the information.
Outstanding Shares:
Purchase the Chongqing Lummy Pharmaceutical Co.,Ltd report to view the information.
Registered Capital:
Purchase the Chongqing Lummy Pharmaceutical Co.,Ltd report to view the information.
Financial Auditors:
Purchase the Chongqing Lummy Pharmaceutical Co.,Ltd report to view the information.
Incorporation Date:
September 06, 1999
Key Executives
Purchase this report to view the information.
Chairman of the Supervisory Board
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Ownership Details
Purchase this report to view the information.
23.43%
Purchase this report to view the information.
11.2%
Purchase this report to view the information.
2.03%
Purchase this report to view the information.
1.05%
Purchase this report to view the information.
0.77%
Subsidiaries
Aijia Hotline Health Management Co., Ltd.
Beijing Lantian Shared Health Management Co., Ltd.
Beijing Yaohua Piaoxiang Pharmaceutical Technology Co., Ltd.
Company Performance
Financial values in the chart are available after Chongqing Lummy Pharmaceutical Co.,Ltd report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CNY. Absolute financial data is included in the purchased report.
Net sales revenue
-6.07%
Total operating revenue
-8.92%
Operating profit (EBIT)
-218.91%
Net Profit (Loss) for the Period
75.73%
Total assets
5.01%
Total equity
0.16%
Operating Profit Margin (ROS)
-4.76%
Net Profit Margin
7.36%
Return on Equity (ROE)
2.3%
Debt to Equity Ratio
1.81%
Quick Ratio
-0.42%
Cash Ratio
-0%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?